|
|
Volumn 12, Issue , 2011, Pages
|
|
A Polypill for primary prevention of cardiovascular disease: A feasibility study of the World Health Organization
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANALGESIC AGENT;
CHOLESTEROL;
POLYPILL;
RED HEART PILL;
UNCLASSIFIED DRUG;
ACETYLSALICYLIC ACID;
ANTITHROMBOCYTIC AGENT;
BIOLOGICAL MARKER;
CARDIOVASCULAR AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
HYDROCHLOROTHIAZIDE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LISINOPRIL;
SIMVASTATIN;
ADULT;
ARTICLE;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
DRUG SAFETY;
FEASIBILITY STUDY;
FEMALE;
FOLLOW UP;
HEALTH BEHAVIOR;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PHYSICIAN;
QUESTIONNAIRE;
RANDOMIZED CONTROLLED TRIAL;
SRI LANKA;
SYSTOLIC BLOOD PRESSURE;
TREATMENT OUTCOME;
WORLD HEALTH ORGANIZATION;
AGED;
ATTITUDE TO HEALTH;
BLOOD;
BLOOD PRESSURE;
CHI SQUARE DISTRIBUTION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG COMBINATION;
DRUG EFFECT;
HEALTH PERSONNEL ATTITUDE;
METHODOLOGY;
MIDDLE AGED;
MULTICENTER STUDY;
PATHOPHYSIOLOGY;
PATIENT COMPLIANCE;
PRIMARY PREVENTION;
RISK ASSESSMENT;
RISK FACTOR;
TIME;
AGED;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ASPIRIN;
ATTITUDE OF HEALTH PERSONNEL;
BIOLOGICAL MARKERS;
BLOOD PRESSURE;
CARDIOVASCULAR AGENTS;
CARDIOVASCULAR DISEASES;
CHI-SQUARE DISTRIBUTION;
CHOLESTEROL;
DIURETICS;
DRUG COMBINATIONS;
FEASIBILITY STUDIES;
FEMALE;
HEALTH KNOWLEDGE, ATTITUDES, PRACTICE;
HUMANS;
HYDROCHLOROTHIAZIDE;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
LISINOPRIL;
MALE;
MEDICATION ADHERENCE;
MIDDLE AGED;
PLATELET AGGREGATION INHIBITORS;
PRIMARY PREVENTION;
QUESTIONNAIRES;
RISK ASSESSMENT;
RISK FACTORS;
SIMVASTATIN;
SRI LANKA;
TIME FACTORS;
TREATMENT OUTCOME;
WORLD HEALTH ORGANIZATION;
|
|
EID: 78650762207
PISSN: 17456215
EISSN: 17456215
Source Type: Journal
DOI: 10.1186/1745-6215-12-3 Document Type: Article |
|
Times cited : (104)
|
|
References (7)
|
